ArticleJournal of computer-aided molecular design2021

High-throughput virtual screening and preclinical analysis identifies CB-1, a novel potent dual B-Raf/c-Raf inhibitor, effective against wild and mutant variants of B-Raf expression in colorectal carcinoma.

Mesfer Al Shahrani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.